Evaluating Monoclonal Gammopathy of Undetermiend Significance (MGUS) with Free Light Chain Assays...

Presented By:
Dr. John V. Mitsios

Speaker Biography:
Dr. Mitsios graduated from the University of Ioannina, Greece with a PhD in Chemistry. Upon completion of his doctoral thesis, he then went on to complete a post-doctoral fellowship at the University of California, San Diego. Dr. Mitsios then transitioned to the world of Clinical Chemistry and completed a fellowship at Washington University in St. Louis, MO. His primary research interest throughout his education and training has been in coagulation, with an emphasis on platelet function and biology. Dr. Mitsios joined Siemens-Healthineers as a clinical consultant as part of the Scientific and Clinical Affairs team. In addition, Dr. Mitsios has co-authored 20 peer-reviewed articles and 3 book chapters.

Webinar:
Evaluating Monoclonal Gammopathy of Undetermiend Significance (MGUS) with Free Light Chain Assays in Clinical Practice

Webinar Abstract:
Multiple myeloma is a cancer of the plasma cell. Plasma cells are white blood cells that make antibodies that help to protect us from infections. However, the cells grow too much in myeloma, crowding out normal cells in the bone marrow that make red blood cells, platelets, and other white blood cells. The purpose of today’s presentation will be to discuss the pathophysiology of multiple myeloma with an emphasis on monoclonal gammopathy of undetermined significance (MGUS). Specifically, the presentation is designed for laboratorians/clinicians who are interested in learning more about the clinical and laboratory investigation of multiple myeloma and MGUS.

LabRoots on Social:
Facebook:   / labrootsinc  
Twitter:   / labroots  
LinkedIn:   / labroots  
Instagram:   / labrootsinc  
Pinterest:   / labroots  
SnapChat: labroots_inc